ABVC BioPharma, Inc.
ABVC
$2.41
-$0.12-4.74%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -1.25M | -2.26M | -842.10K | 229.30K | -394.80K |
| Total Depreciation and Amortization | 96.00K | 80.80K | 113.90K | 179.30K | 106.40K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.18M | 1.65M | 207.60K | -681.70K | 285.00K |
| Change in Net Operating Assets | -158.20K | -365.90K | -19.30K | -220.60K | 63.60K |
| Cash from Operations | -133.30K | -894.20K | -539.80K | -493.60K | 60.20K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -1.27M | -665.80K | -- | -- | 44.80K |
| Cash from Investing | -1.27M | -665.80K | -- | -- | 44.80K |
| Total Debt Issued | 150.00K | 9.00K | -- | 689.60K | -673.50K |
| Total Debt Repaid | -335.70K | -74.10K | -29.30K | -177.00K | -179.10K |
| Issuance of Common Stock | 1.32M | 2.04M | 411.70K | 76.30K | 771.20K |
| Repurchase of Common Stock | -- | -- | -- | -7.30K | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -46.30K | 46.30K | 0.00 | 0.00 |
| Cash from Financing | 1.13M | 1.93M | 428.80K | 581.50K | -81.40K |
| Foreign Exchange rate Adjustments | 51.80K | -50.60K | 6.80K | 6.10K | 3.40K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -222.40K | 316.80K | -104.20K | 93.90K | 27.10K |